Bausch + Lomb’s First Results Look Familiar
First Full-Year Guidance: $3.75bn To $3.8bn Revenues On 4% To 5% Gtowth
January-March results Bausch + Lomb reported on 8 June were included in Bausch Health’s results published in May on the same day it closed an IPO shares to separate its eye health and vision care business. Guidance it provided, however, was new and a first for Bausch + Lomb.
